These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1920495)

  • 1. Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent.
    Jordan VC; Fritz NF; Langan-Fahey S; Thompson M; Tormey DC
    J Natl Cancer Inst; 1991 Oct; 83(20):1488-91. PubMed ID: 1920495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen.
    Ravdin PM; Fritz NF; Tormey DC; Jordan VC
    Cancer Res; 1988 Feb; 48(4):1026-9. PubMed ID: 3123050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer.
    Jordan VC; Fritz NF; Tormey DC
    Cancer Res; 1987 Jan; 47(2):624-30. PubMed ID: 3098415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women.
    Sherman BM; Chapler FK; Crickard K; Wycoff D
    J Clin Invest; 1979 Aug; 64(2):398-404. PubMed ID: 110834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex hormones in postmenopausal women with breast cancer on tamoxifen.
    Kostoglou-Athanassiou I; Ntalles K; Gogas J; Markopoulos C; Alevizou-Terzaki V; Athanassiou P; Georgiou E; Proukakis C
    Horm Res; 1997; 47(3):116-20. PubMed ID: 9050950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in postmenopausal breast cancer patients.
    Lønning PE; Johannessen DC; Lien EA; Ekse D; Fotsis T; Adlercreutz H
    J Steroid Biochem Mol Biol; 1995 May; 52(5):491-6. PubMed ID: 7748814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of adjuvant therapy with or without tamoxifen on the endocrine function of patients with breast cancer.
    Yasumura T; Akami T; Mitsuo M; Oka T; Naitoh K; Yamamoto T; Honjyo H; Okada H
    Jpn J Surg; 1990 Jul; 20(4):369-75. PubMed ID: 2117682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of treatment with tamoxifen on serum levels of various steroid and protein hormones in women with breast cancer].
    Grodecka-Gazdecka S; Kociałkowski K; Chwalisz K; Baron J
    Endokrynol Pol; 1985; 36(6):341-8. PubMed ID: 3833535
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide.
    Johansson H; Bonanni B; Gandini S; Guerrieri-Gonzaga A; Cazzaniga M; Serrano D; Macis D; Puccio A; Sandri MT; Gulisano M; Formelli F; Decensi A
    Breast Cancer Res Treat; 2013 Dec; 142(3):569-78. PubMed ID: 24241787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Concentration of selected sex hormones and SHBG in the serum of women with breast cancer treated with antiestrogens and (or) cytostatic agents].
    Grodecka-Gazdecka S; Kociałkowski K
    Nowotwory; 1990; 40(1):5-11. PubMed ID: 2356147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy.
    Bellet M; Gray KP; Francis PA; Láng I; Ciruelos E; Lluch A; Climent MA; Catalán G; Avella A; Bohn U; González-Martin A; Ferrer R; Catalán R; Azaro A; Rajasekaran A; Morales J; Vázquez J; Fleming GF; Price KN; Regan MM
    J Clin Oncol; 2016 May; 34(14):1584-93. PubMed ID: 26729437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    CMAJ; 1998 Feb; 158 Suppl 3():S52-64. PubMed ID: 9484279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternating tamoxifen and medroxyprogesterone acetate in postmenopausal advanced breast cancer patients--short and long term endocrine effects.
    Canobbio L; Galligioni E; Gasparini G; Fassio T; Crivellari D; Villalta D; Santini G; Monfardini S; Boccardo F
    Breast Cancer Res Treat; 1987 Nov; 10(2):201-4. PubMed ID: 3427228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian ablation for premenopausal breast cancer: A review of treatment considerations and the impact of premature menopause.
    Nourmoussavi M; Pansegrau G; Popesku J; Hammond GL; Kwon JS; Carey MS
    Cancer Treat Rev; 2017 Apr; 55():26-35. PubMed ID: 28288389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic-pituitary-ovarian axis in women with operable breast cancer treated with adjuvant CMF and tamoxifen.
    Delrio G; De Placido S; Pagliarulo C; d'Istria M; Fasano S; Marinelli A; Citarella F; De Sio L; Contegiacomo A; Iaffaioli RV
    Tumori; 1986 Feb; 72(1):53-61. PubMed ID: 3754071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant endocrine therapy for premenopausal women with hormone-responsive breast cancer.
    Mathew A; Davidson NE
    Breast; 2015 Nov; 24 Suppl 2():S120-5. PubMed ID: 26255743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of tamoxifen in the treatment and prevention of breast cancer.
    Jordan VC
    Curr Probl Cancer; 1992; 16(3):129-76. PubMed ID: 1582240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.